Abstract
We performed a meta-analysis to assess whether MC1R variants increase the risk of melanoma in CDKN2A mutation carriers of melanoma-prone families.
Lingua originale | English |
---|---|
pagine (da-a) | 1413-1420 |
Numero di pagine | 8 |
Rivista | European Journal of Cancer |
Volume | 46 |
DOI | |
Stato di pubblicazione | Pubblicato - 2010 |
Keywords
- Australia
- Cyclin-Dependent Kinase Inhibitor p16
- Europe
- Female
- Genetic Predisposition to Disease
- Genetic Variation
- Humans
- Male
- Melanoma
- Mutation
- Odds Ratio
- Pedigree
- Receptor, Melanocortin, Type 1
- Skin Neoplasms
- United States